Phase I and II metabolites of methylenedioxy-substituted stimulants interact with human monoamine transporters
Kolaczynska, K. E., Luethi, D., Rice, K. C., Blough, B. E., Baumann, M. H., & Liechti, M. E. (2019). Phase I and II metabolites of methylenedioxy-substituted stimulants interact with human monoamine transporters. Clinical Toxicology, 57(6), 531-532.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments
Tailoring off the shelf global evidence with local implementation research can boost action on overweight and obesity